Skip to main content
Log in

Coagulation Profile at Diagnosis in Patients with Acute Lymphoblastic Leukemia

  • Original Article
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Objective

To evaluate the coagulation parameters at the time of diagnosis in pediatric acute lymphoblastic leukemia (ALL) patients.

Methods

A total of 65 newly diagnosed ALL patients upto 18 y of age along with 30 age and sex matched controls were included in the study. Coagulation tests including Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), Fibrinogen (FBG) assay, D-dimer (D-DI) assay, Coagulation inhibitor levels and tests for fibrinolysis were performed.

Results

At baseline, APTT of the patients was significantly prolonged (p 0.033), but PT and fibrinogen were comparable in the two groups. Protein C (PC) and Protein S (PS) were both significantly reduced in the cases, while antithrombin was comparable to control values (p < 0.001, p < 0.001 & p = 0.828 respectively). Tissue plasminogen activator levels (tPA) were significantly lower in the cases (p < 0.001) but Plasminogen activator inhibitor type 1 (PAI-1) values were comparable. D-DI levels were significantly high (p < 0.001).

Conclusions

The onset of leukemia is associated with hemostatic derangement favouring hypercoagulability. The coagulopathy is due to thrombin activation (as evidenced by raised d-dimer). The decreased fibrinolysis (due to reduced tPA and raised PAI-1) and low levels of PC and PS contribute to the hypercoagulable state at the time of diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Young YL, Miller RW. Incidence of malignant tumors in U.S. children. J Pediatr. 1975;86:254–8.

    Article  PubMed  Google Scholar 

  2. Swerdlow SH, Camp E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: International Agency for Research on Cancer; 2008. p. 168.

    Google Scholar 

  3. Athale UH, Chan AK. Thrombosis in children with acute lymphoblastic leukemia: part I. Epidemiology of thrombosis in children with acute lymphoblastic leukemia. Thromb Res. 2003;111:125–31.

    Article  CAS  PubMed  Google Scholar 

  4. Caruso V, Iacoviello L, Di Castelnuovo A, et al. Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients. Blood. 2006;108:2216–22.

    Article  CAS  PubMed  Google Scholar 

  5. Ku GH, White RH, Chew HK, Harvey DJ, Zhou H, Wun T. Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival. Blood. 2009;113:3911–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Celkan T. Thrombosis in pediatric acute lymphoblastic leukemia. Austral-Asian J Cancer. 2008;7:203–19.

    Google Scholar 

  7. Priest JR, Ramsay NK, Bennett AJ, Krivit W, Edson JR. The effect of l-asparaginase on antithrombin, plasminogen, and plasma coagulation during therapy for acute lymphoblastic leukemia. J Pediatr. 1982;100:990–5.

    Article  CAS  PubMed  Google Scholar 

  8. Ribeiro RC, Pui CH. The clinical and biological correlates of coagulopathy in children with acute leukemia. J Clin Oncol. 1986;4:1212–8.

    CAS  PubMed  Google Scholar 

  9. Homans AC, Rybak ME, Baglini RL, Tiarks C, Steiner ME, Forman EN. Effect of l-asparaginase administration on coagulation and platelet function in children with leukemia. J Clin Oncol. 1987;5:811–7.

    CAS  PubMed  Google Scholar 

  10. Giordano P, Molinari AC, Del Vecchio GC, et al. Prospective study of hemostatic alterations in children with acute lymphoblastic leukemia. Am J Hematol. 2010;85:325–30.

    CAS  PubMed  Google Scholar 

  11. Abshire TC, Gold SH, Odom LF, Carson SD, Hathaway WF. The coagulopathy of childhood leukemia. Thrombin activation or primary fibrinolysis? Cancer. 1990;66:716–21.

    Article  CAS  PubMed  Google Scholar 

  12. Mitchell L, Hoogendoorn H, Giles AR, Vegh P, Andrew M. Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: risk of thrombotic complications in l-asparaginase induced antithrombin deficiency. Blood. 1994;83:386–91.

    CAS  PubMed  Google Scholar 

  13. Oner AG, Gurgey A, Kirazli S, Okur H, Tunc B. Changes of hemostatic factors in children with acute lymphoblastic leukemia receiving combined chemotherapy including high dose methylprednisolone and l-asparaginase. Leuk Lymphoma. 1999;33:361–4.

    Article  CAS  PubMed  Google Scholar 

  14. Mitchell LG, Halton JM, Vegh PA, et al. Effect of disease and chemotherapy on haemostasis in children with acute lymphoid leukemia. Am J Pediatr Hematol Oncol. 1994;16:120–6.

    CAS  PubMed  Google Scholar 

  15. Dixit A, Kannan M, Mahapatra M, Choudhry VP, Saxena R. Roles of protein C, protein S, and antithrombin III in acute leukemia. Am J Hematol. 2006;81:171–4.

    Article  CAS  PubMed  Google Scholar 

  16. Mall V, Thomas KB, Sauter S, Niemeyer CM, Sutor AH. Effect of glucocorticoids, E.Coli and Erwinia l-asparaginase on haemostatic proteins in children with acute lymphoblastic leukemia. Klin Padiatr. 1999;211:205–10.

    Article  CAS  PubMed  Google Scholar 

  17. Legnani C, Palareti G, Pession A, et al. Intravascular coagulation phenomena associated with prevalent fall in fibrinogen and plasminogen during l-asparaginase treatment in leukemia children. Haemostasis. 1988;18:179–86.

    CAS  PubMed  Google Scholar 

  18. Semeraro N, Montemurro P, Giordano P, et al. Unbalanced coagulation-fibrinolysis potential during l-asparaginase therapy in children with acute lymphoblastic leukemia. Thromb Haemost. 1990;64:38–40.

    CAS  PubMed  Google Scholar 

  19. Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L. Maturation of the hemostatic system during childhood. Blood. 1992;80:1998–2005.

    CAS  PubMed  Google Scholar 

  20. Kwaan HC. Double hazard of thrombophilia and bleeding in leukemia. Hematology Am Soc Hematol Educ Program. 2007;1:151–7.

    Google Scholar 

Download references

Acknowledgments

The authors thank Dr. Bhavuk Garg for help in statistical analysis and Dr. Arushi Sehgal for help with data compilation and statistical analysis.

Contributions

SS: Conducted the study, performed the tests and statistics, analysed the data and wrote the article. SS: Supervised the study, edited the article and will act as guarantor for the paper; JC and AN: Supervised the study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shivali Sehgal.

Ethics declarations

Conflict of Interest

None.

Source of Funding

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sehgal, S., Sharma, S., Chandra, J. et al. Coagulation Profile at Diagnosis in Patients with Acute Lymphoblastic Leukemia. Indian J Pediatr 83, 1082–1086 (2016). https://doi.org/10.1007/s12098-016-2114-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-016-2114-2

Keywords

Navigation